STEPHANIE ALLAN: Open Payments
NPI 1326405598 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 50 payments from 10 companies in 2025. Trend: 2023 $802 · 2024 $560 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $177 |
| Lundbeck LLC | 12 | $148 |
| Corium, LLC | 5 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| ABBVIE INC. | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Alkermes, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
Products named: Qelbree, REXULTI, Azstarys, FANAPT, VRAYLAR, Auvelity, SPRAVATO, ARISTADA.
Industry payments across FL — which companies pay providers there.
